In one paragraphArticle in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
4 authors.
Anna L GregoryDepartment of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID 0000-0001-5363-6385 Hailey E BussanMicrobiology Doctoral Training Program, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Madeline A TopfDepartment of Medical Microbiology & Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Andrew J HryckowianDepartment of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID 0000-0002-8956-6259 Funding
Research Training for Computation and Informatics in Biology and MedicineT15LM007359 · NLM · UNIVERSITY OF WISCONSIN-MADISON · PI Mark W. Craven, Colin Noel Dewey · 2002 to 2026
$22.6MDiversity Supplement: Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infectionR01AI139261 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Kevin W Garey, Julian G Hurdle · 2018 to 2026
$6.0MHHS | National Institutes of Health (NIH) R01AI139261HHS | National Institutes of Health (NIH) T15LM007359NIAID NIH HHS R01 AI139261NLM NIH HHS T15 LM007359NSF | National Science Foundation Graduate Research Fellowship Program (GRFP) DGE-2137424University of Wisconsin-Madison (UW) Startup funds
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Bacterial ProteinsClostridioides difficileClostridium InfectionsGene Expression Regulation, BacterialOxygenRepressor ProteinsAnimalsDisease Models, AnimalFemaleMiceBacterial ProteinsOxygenRepressor ProteinsanaerobesClostridium difficileoxidative stresstranscriptional repression
Identifiers
PMID39846733
PMCPMC11841134
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390